Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval
July 21, 2017 at 07:34 AM EDT
July 21 (Reuters) - European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer called Merkel cell carcinoma.
